Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

251 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Hepatitis C].
Bjøro K, Schrumpf E. Bjøro K, et al. Tidsskr Nor Laegeforen. 1992 Nov 30;112(29):3654-5. Tidsskr Nor Laegeforen. 1992. PMID: 1471122 Norwegian. No abstract available.
Validation of a cholangiographic prognostic model in primary sclerosing cholangitis.
Ponsioen CY, Reitsma JB, Boberg KM, Aabakken L, Rauws EA, Schrumpf E. Ponsioen CY, et al. Endoscopy. 2010 Sep;42(9):742-7. doi: 10.1055/s-0030-1255527. Epub 2010 Jul 9. Endoscopy. 2010. PMID: 20623444
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
Karlsen TH, Boberg KM, Vatn M, Bergquist A, Hampe J, Schrumpf E, Thorsby E, Schreiber S, Lie BA; IBSEN Study Group. Karlsen TH, et al. Genes Immun. 2007 Apr;8(3):275-8. doi: 10.1038/sj.gene.6364377. Epub 2007 Feb 15. Genes Immun. 2007. PMID: 17301827 Clinical Trial.
The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.
Boberg KM, Spurkland A, Rocca G, Egeland T, Saarinen S, Mitchell S, Broomé U, Chapman R, Olerup O, Pares A, Rosina F, Schrumpf E. Boberg KM, et al. Scand J Gastroenterol. 2001 Aug;36(8):886-90. doi: 10.1080/003655201750313441. Scand J Gastroenterol. 2001. PMID: 11495087
RESULTS: The DRB1*03,DQA1*0501, DQB1*02 (i.e. DR3,DQ2) heterozygous genotype was associated with an increased risk of death or liver transplantation (hazard ratio = 1.63; 95% confidence interval (CI) = 1.06-2.52). ...
RESULTS: The DRB1*03,DQA1*0501, DQB1*02 (i.e. DR3,DQ2) heterozygous genotype was associated with an increased risk of death or liver …
Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.
Bansi DS, Bauducci M, Bergqvist A, Boberg K, Broome U, Chapman R, Fleming K, Jorgensen R, Lindor K, Rosina F, Schrumpf E. Bansi DS, et al. Eur J Gastroenterol Hepatol. 1997 Jun;9(6):575-80. doi: 10.1097/00042737-199706000-00005. Eur J Gastroenterol Hepatol. 1997. PMID: 9222729 Clinical Trial.
Hepatic retention of copper and selenium in primary sclerosing cholangitis.
Aaseth J, Thomassen Y, Aadland E, Fausa O, Schrumpf E. Aaseth J, et al. Scand J Gastroenterol. 1995 Dec;30(12):1200-3. doi: 10.3109/00365529509101631. Scand J Gastroenterol. 1995. PMID: 9053974
Etiology and pathogenesis in primary sclerosing cholangitis.
Boberg KM, Lundin KE, Schrumpf E. Boberg KM, et al. Scand J Gastroenterol Suppl. 1994;204:47-58. doi: 10.3109/00365529409103625. Scand J Gastroenterol Suppl. 1994. PMID: 7824878 Review.
Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases.
Zauli D, Baffoni L, Cassani F, Fusconi M, Lenzi M, Ballardini G, Luigi M, Bianchi FB, Schrumpf E. Zauli D, et al. Gastroenterology. 1992 Mar;102(3):1088-90. doi: 10.1016/0016-5085(92)90213-i. Gastroenterology. 1992. PMID: 1537507 No abstract available.
[Primary sclerosing cholangitis and inflammatory bowel disease].
Schrumpf E, Fausa O, Aadland E, Elgjo K, Kolmannskog F. Schrumpf E, et al. Tidsskr Nor Laegeforen. 1990 Apr 10;110(10):1212-6. Tidsskr Nor Laegeforen. 1990. PMID: 1970674 Norwegian.
251 results
Jump to page
Feedback